Sphingosine-1 phosphate receptor-1 agonist - Bristol-Myers SquibbAlternative Names: S1P1 modulator
Latest Information Update: 01 Oct 2015
At a glance
- Originator Bristol-Myers Squibb
- Class Small molecules
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Immunological disorders
Most Recent Events
- 31 Dec 2012 Preclinical trials in Immunological disorders in USA (unspecified route)